Increased expression and local accumulation of the Prion Protein, Alzheimer Aβ peptides, superoxide dismutase 1, and Nitric oxide synthases 1 & 2 in muscle in a rabbit model of diabetes
Autor: | Peter H. Frederikse, Claudine L. Bitel, Yicheng Feng, Nizar Souayah |
---|---|
Rok vydání: | 2010 |
Předmět: |
Muscle tissue
medicine.medical_specialty Amyloid Prions Physiology SOD1 Gene Expression Nitric Oxide Synthase Type II Nitric Oxide Synthase Type I lcsh:Physiology Presenilin Nitric oxide Superoxide dismutase chemistry.chemical_compound Superoxide Dismutase-1 Physiology (medical) Internal medicine medicine Animals Humans Amyloid beta-Peptides lcsh:QP1-981 biology Superoxide Dismutase Muscles Neurodegeneration General Medicine medicine.disease Streptozotocin Disease Models Animal medicine.anatomical_structure Endocrinology Biochemistry chemistry biology.protein Rabbits Research Article medicine.drug |
Zdroj: | BMC Physiology BMC Physiology, Vol 10, Iss 1, p 18 (2010) |
ISSN: | 1472-6793 |
DOI: | 10.1186/1472-6793-10-18 |
Popis: | Background Muscle disease associated with different etiologies has been shown to produce localized accumulations of amyloid and oxidative stress-related proteins that are more commonly associated with neurodegeneration in the brain. In this study we examined changes in muscle tissue in a classic model of diabetes and hyperglycemia in rabbits to determine if similar dysregulation of Alzheimer Aβ peptides, the prion protein (PrP), and superoxide dismutase 1 (SOD1), as well as nitric oxide synthases is produced in muscle in diabetic animals. This wild-type rabbit model includes systemic physiological expression of human-like Alzheimer precursor proteins and Aβ peptides that are considered key in Alzheimer protein studies. Results Diabetes was produced in rabbits by injection of the toxic glucose analogue alloxan, which selectively enters pancreatic beta cells and irreversibly decreases insulin production, similar to streptozotocin. Quadriceps muscle from rabbits 16 wks after onset of diabetes and hyperglycemia were analyzed with biochemical and in situ methods. Immunoblots of whole muscle protein samples demonstrated increased PrP, SOD1, as well as neuronal and inducible Nitric oxide synthases (NOS1 and NOS2) in diabetic muscle. In contrast, we detected little change in Alzheimer Aβ precursor protein expression, or BACE1 and Presenilin 1 levels. However, Aβ peptides measured by ELISA increased several fold in diabetic muscle, suggesting a key role for Aβ cleavage in muscle similar to Alzheimer neurodegeneration in this diabetes model. Histological changes in diabetic muscle included localized accumulations of PrP, Aβ, NOS1 and 2, and SOD1, and evidence of increased central nuclei and cell infiltration. Conclusions The present study provides evidence that several classic amyloid and oxidative stress-related disease proteins coordinately increase in overall expression and form localized accumulations in diabetic muscle. The present study highlights the capacity of this wild-type animal model to produce an array of hallmark pathological features that have also been described in other muscle diseases. |
Databáze: | OpenAIRE |
Externí odkaz: |